Death from the more serious form of the disease is highest among adults 50 and above, Merck said in a release in December. Even after the FDA approval, the company's single-dose vaccine won't ...

Sanofi expands its U.S. manufacturing with a $20 billion investment. The FDA approves Merck's cancer drug for rare adrenal ...